Antiva Biosciences (Series D)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$50,000,000
Company Info
Founders
Kristine Ball
Market
Healthcare & Wellness
Coinvestors
Adjuvant Capital,Google Ventures (GV)
Company Description

Topical treatment for precancerous lesions for cervical cancer. Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection.

Links
WebsiteCrunchbaseLinkedIn
Back to HomeBack to Healthcare and Biotech DealsView Funding Announcement